Back

A ncBAF to cBAF Switch Regulates Human Hematopoietic Progenitor Myeloid Differentiation

Adelman, E. R.; Adele, A. A.; Ricardo Gutierrez Silva, C.; Pilala, K.; Garcia-Martinez, L.; Teran Pumar, O.; Beckedorff, F.; Cingaram, P. R.; Chakrabarti, R.; Bayik, D.; Shiekhattar, R.; Morey, L.; Figueroa, M. E.

2026-10-02 cancer biology
10.64898/2026.10.01.755757 bioRxiv
Show abstract

The mammalian BRG-/BRM-associated factor (BAF) chromatin remodeling complexes are crucial regulators of hematopoietic stem and progenitor cell (HSPC) fate. Expression of the ncBAF subcomponent, BRD9, is altered in both normal aging and myeloid malignancies. We find that in adult human HSPC, BRD9 regulates the differentiation of myeloid progenitors. Upon degradation of BRD9 in these cells, ncBAF is displaced from the chromatin, leading in turn to enhanced recruitment of cBAF to bona fide CEBPA target sites. With the shift from ncBAF to cBAF, HSPC differentiation results in increased generation of myeloid-derived suppressor cells (MDSC) that secrete elevated levels of IL-8. Soluble factors from these myeloid cells, which have lost BRD9, enhance the stemness of breast cancer cells in vitro. In contrast, bromodomain inhibition of BRD9 results in minimal alterations of ncBAF binding and myeloid differentiation, indicating that BRD9 acts as a barrier to human MDSC differentiation in a bromodomain-independent manner.

Matching journals

The top 5 journals account for 50% of the predicted probability mass.

50% of probability mass above

"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.